QL
JAZZ icon

Quarry LP’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quarry LP’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,125
Closed -$280K – 2373
2025
Q3 		$280K Sell
2,125
-1,475
-41% -$177K 0.06% 274
2025
Q2 		$382K Buy
3,600
+2,400
+200% +$261K 0.08% 217
2025
Q1 		$149K Sell
1,200
-500
-29% -$65.2K 0.03% 374
2024
Q4 		$209K Buy
1,700
+100
+6% +$11.8K 0.03% 240
2024
Q3 		$178K Buy
+1,600
New +$175K 0.04% 265

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Quarry LP's JAZZ Position: Q4 2025 in Review

Quarry LP sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 2,125 shares — an estimated $280K sold.

Quarry LP first reported a position in JAZZ in Q3 2024 and held it in 5 quarters. The position peaked at $382K in Q2 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • Quarry LP reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Quarry LP sold 2,125 Jazz Pharmaceuticals shares in Q4 2025, an estimated $280K.
  • Quarry LP first reported a position in Jazz Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Quarry LP's Jazz Pharmaceuticals position peaked at $382K in Q2 2025.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.